188 related articles for article (PubMed ID: 16752296)
1. Moxifloxacin superior to vancomycin for treatment of bone infections--a study in rats.
Kalteis T; Beckmann J; Schröder HJ; Handel M; Grifka J; Lehn N; Lerch K
Acta Orthop; 2006 Apr; 77(2):315-9. PubMed ID: 16752296
[TBL] [Abstract][Full Text] [Related]
2. Treatment of implant-associated infections with moxifloxacin: an animal study.
Kalteis T; Beckmann J; Schröder HJ; Schaumburger J; Linde HJ; Lerch K; Lehn N
Int J Antimicrob Agents; 2006 May; 27(5):444-8. PubMed ID: 16621461
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of moxifloxacin compared to teicoplanin in the treatment of implant-related chronic osteomyelitis in rats.
Ozturan KE; Yucel I; Kocoglu E; Cakici H; Guven M
J Orthop Res; 2010 Oct; 28(10):1368-72. PubMed ID: 20839321
[TBL] [Abstract][Full Text] [Related]
4. Staphylococcus aureus mediastinitis and sternal osteomyelitis following median sternotomy in a rat model.
Barnea Y; Carmeli Y; Kuzmenko B; Navon-Venezia S
J Antimicrob Chemother; 2008 Dec; 62(6):1339-43. PubMed ID: 18799473
[TBL] [Abstract][Full Text] [Related]
5. Effects of intravitreal moxifloxacin and dexamethasone in experimental Staphylococcus aureus endophthalmitis.
Ermis SS; Cetinkaya Z; Kiyici H; Inan UU; Ozturk F
Curr Eye Res; 2007 Apr; 32(4):337-44. PubMed ID: 17453955
[TBL] [Abstract][Full Text] [Related]
6. Daptomycin treatment of Staphylococcus aureus experimental chronic osteomyelitis.
Rouse MS; Piper KE; Jacobson M; Jacofsky DJ; Steckelberg JM; Patel R
J Antimicrob Chemother; 2006 Feb; 57(2):301-5. PubMed ID: 16361330
[TBL] [Abstract][Full Text] [Related]
7. Treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus with a synthetic carrier of calcium sulphate (Stimulan) releasing moxifloxacin.
Kanellakopoulou K; Galanopoulos I; Soranoglou V; Tsaganos T; Tziortzioti V; Maris I; Papalois A; Giamarellou H; Giamarellos-Bourboulis EJ
Int J Antimicrob Agents; 2009 Apr; 33(4):354-9. PubMed ID: 19097865
[TBL] [Abstract][Full Text] [Related]
8. Intracameral Vigamox (moxifloxacin 0.5%) is non-toxic and effective in preventing endophthalmitis in a rabbit model.
Kowalski RP; Romanowski EG; Mah FS; Yates KA; Gordon YJ
Am J Ophthalmol; 2005 Sep; 140(3):497-504. PubMed ID: 16083841
[TBL] [Abstract][Full Text] [Related]
9. Characterization of biodegradable chitosan microspheres containing vancomycin and treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus with prepared microspheres.
Cevher E; Orhan Z; Mülazimoğlu L; Sensoy D; Alper M; Yildiz A; Ozsoy Y
Int J Pharm; 2006 Jul; 317(2):127-35. PubMed ID: 16624509
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment with moxifloxacin of experimental aortic valve endocarditis due to methicillin-resistant Staphylococcus aureus (MRSA).
Galani L; Pefanis A; Sakka V; Iliopoulos D; Donta I; Triantafyllidi H; Skiadas I; Karayiannakos P; Giamarellou H
Int J Antimicrob Agents; 2009 Jan; 33(1):65-9. PubMed ID: 18818055
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of hydroxyapatite-vancomycin bone cement in the treatment of Staphylococcus aureus induced chronic osteomyelitis.
Joosten U; Joist A; Gosheger G; Liljenqvist U; Brandt B; von Eiff C
Biomaterials; 2005 Sep; 26(25):5251-8. PubMed ID: 15792552
[TBL] [Abstract][Full Text] [Related]
12. Therapy with gentamicin-PMMA beads, gentamicin-collagen sponge, and cefazolin for experimental osteomyelitis due to Staphylococcus aureus in rats.
Mendel V; Simanowski HJ; Scholz HC; Heymann H
Arch Orthop Trauma Surg; 2005 Jul; 125(6):363-8. PubMed ID: 15864679
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of telavancin in the treatment of methicillin-resistant Staphylococcus aureus osteomyelitis: studies with a rabbit model.
Yin LY; Calhoun JH; Thomas TS; Wirtz ED
J Antimicrob Chemother; 2009 Feb; 63(2):357-60. PubMed ID: 19060292
[TBL] [Abstract][Full Text] [Related]
14. Synergy of HBO2 and a local antibiotic carrier for experimental osteomyelitis due to Staphylococcus aureus in rats.
Mendel V; Simanowski HJ; Scholz HCh
Undersea Hyperb Med; 2004; 31(4):407-16. PubMed ID: 15686272
[TBL] [Abstract][Full Text] [Related]
15. A simple infection model using pre-colonized implants to reproduce rat chronic Staphylococcus aureus osteomyelitis and study antibiotic treatment.
Monzón M; García-Alvarez F; Laclériga A; Gracia E; Leiva J; Oteiza C; Amorena B
J Orthop Res; 2001 Sep; 19(5):820-6. PubMed ID: 11562127
[TBL] [Abstract][Full Text] [Related]
16. Preliminary investigations on a new gentamicin and vancomycin-coated PMMA nail for the treatment of bone and intramedullary infections: An experimental study in the rabbit.
Giavaresi G; Borsari V; Fini M; Giardino R; Sambri V; Gaibani P; Soffiatti R
J Orthop Res; 2008 Jun; 26(6):785-92. PubMed ID: 18186130
[TBL] [Abstract][Full Text] [Related]
17. Vascular graft infection by Staphylococcus aureus: efficacy of cefazolin, teicoplanin and vancomycin prophylaxis protocols in a rat model.
Atahan E; Gul M; Ergun Y; Eroglu E
Eur J Vasc Endovasc Surg; 2007 Aug; 34(2):182-7. PubMed ID: 17481929
[TBL] [Abstract][Full Text] [Related]
18. Tissue concentrations of vancomycin and Moxifloxacin in periprosthetic infection in rats.
Beckmann J; Kees F; Schaumburger J; Kalteis T; Lehn N; Grifka J; Lerch K
Acta Orthop; 2007 Dec; 78(6):766-73. PubMed ID: 18236182
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of vancomycin, teicoplanin and fusidic acid as prophylactic agents in prevention of vascular graft infection: an experimental study in rat.
Yasim A; Gul M; Atahan E; Ciragil P; Aral M; Ergun Y
Eur J Vasc Endovasc Surg; 2006 Mar; 31(3):274-9. PubMed ID: 16360328
[TBL] [Abstract][Full Text] [Related]
20. Treatment of methicillin-resistant Staphylococcus aureus experimental osteomyelitis with ciprofloxacin or vancomycin alone or in combination with rifampin.
Henry NK; Rouse MS; Whitesell AL; McConnell ME; Wilson WR
Am J Med; 1987 Apr; 82(4A):73-5. PubMed ID: 3578332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
